12/30/2022Abbott to Exit China's Pediatric Nutrition Market

9/14/2018Chinese Drug-releasing Heart Stent Clears Clinical Trials in Europe

1/18/2017Abbott Disbands Sales Team of Ensure Products, Letting Go 200 Employee...

7/18/2014Abbvie to Acquire Shire for US$55 Billion

1/20/2014Abbott Alleged to Bribe Doctors for Higher Sales of Medical Nutritiona...

12/10/2013Chinese Partner of Shanghai Abbott Lists Its 25% Stake for Sale

6/14/2013AbbVie Officially Sets Up Shop in China

1/2/2013AbbVie Completes Spinoff from Abbott

4/11/2012Abbott's Humira set to become the top-selling drug globally this year

3/23/2012Abbott's infant formula fails Chinese standards

1/10/2012Abbott China exposed of more alleged physician briberies

1/6/2012Abbott gets 2011 China Best Corporate Citizenship Award

11/7/2011Vice Health Minister meets visiting Abbott executive

10/19/2011Abbott to split into two companies

8/17/2011Abbott to invest US$230M into a new nutrition facility in China

6/10/2011Abbott denies any involvements with commercial briberies in China

1/26/2011Abbott announces another cut of 2% workforce

10/13/2010Chinese manufacturers of Sibutramine hang on to their products for now

9/27/2010Abbott Labs to slash 3,000 pharma jobs after Solvay acquisition

8/18/2010Abbott launches HUMIRA in China

6/29/2010Abbott may sell its vaccine business

5/21/2010Abbott acquires Piramal's healthcare solutions unit for $3.72B

5/11/2010Abbott enter generic drug pack with India's Zydus Cadila for emerging ...

4/30/2010Abbott launches new diabetic nutrition in China

2/26/2010SFDA issues alert on Sibutramine

2/17/2010Abbott completes $4.5B acquisition of Solvay Pharma

11/12/2009Abbott succeeds in China by focusing on nutribution business

9/28/2009Abbott gets Solvay's pharma business for US$7.6 billion

9/25/2009Nycomed likely to raise its bid for Solvay's drug business unit

9/18/2009Abbott on the lookout for a major acquisition

Page:1/2 Total number of articles:34: [First][<<] [1] [2] [>>] [End]